Marble, columns and stairs
Marble, columns and stairs
https://mcmillan.ca/wp-content/uploads/2017/11/dealscases_desktop.jpg
post

McMillan advises Assa Abloy of Canada on its acquisition of Wallace Group of Companies

Feb 28, 2025

On February 28, 2025, Assa Abloy of Canada Ltd., completed its acquisition of Wallace & Wallace and Wallace Perimeter Security, together Wallace Group of Companies.

post

McMillan advises Underwriters in connection with AbraSilver Resource Corp.’s Public Offering

Feb 7, 2025

AbraSilver Resource Corp. closes C$30M offering for 11.7M shares, advancing its Diablillos silver-gold project in Argentina.

post

McMillan Advises Resource Label Group on its Acquisition of Imprimerie Ste-Julie

Feb 4, 2025

On February 4, 2025, Resource Label Group, LLC completed its acquisition of Imprimerie Ste-Julie Inc, a Quebec corporation providing customized label solutions to customers in the food, beverage, pharmaceuticals, natural products and cosmetics industries.

post

McMillan Advises Kilmer Capital Partners on its Acquisition of Brunswick Lift Rentals Ltd

Jan 31, 2025

On January 31, 2025, Kilmer Capital Partners completed its acquisition of Brunswick Lift Rentals Ltd.

post

McMillan Advises BlueMatrix LLC on its Acquisition of Street Context

Jan 17, 2025

On January 17, 2025, funds advised by BlueMatrix Parent, LP, a portfolio company of Thoma Bravo, completed the acquisition of Quantify Labs Inc. d/b/a/ Street Context

post

McMillan Advises Great Canadian Gaming Corporation on its Sale of Casino Nanaimo and Elements Casino Victoria

Jan 16, 2025

On January 16, 2025, Great Canadian Gaming Corporate completed its previously announced definitive agreements to sell Casino Nanaimo and Elements Casino Victoria to Petroglyph Development Group Ltd., a wholly owned corporation of Snuneymuxw First Nation.

post

McMillan Advises SK Capital on its Acquisition of Spectra Confectionery

Nov 15, 2024

On November 15, 2024, funds advised by SK Capital Partners, LP completed the acquisition of Spectra Confectionery Limited.

post

McMillan advised Bright Minds Bioscience on its USD$35 Million Non-Brokered Private Placement

Nov 4, 2024

Bright Minds Bioscience Inc. (CSE: DRUG, NASDAQ: DRUG) has closed a USD $35 million non-brokered private placement on November 4, 2024, issuing 1,612,902 common shares at USD $21.70 per share.

post

McMillan advises Underwriters in connection Collective Mining Ltd.’s Public Offering

Oct 28, 2024

On October 28, 2024, Collective Mining Ltd. (CNL) closed a C$40.25M bought deal offering of 8,050,000 common shares, including full exercise of the underwriters' over-allotment option.